(Q46915357)

26 December 2017

title

Radioiodinated clioquinol as a biomarker for beta-amyloid: Zn complexes in Alzheimer's disease (English)

1 reference

26 December 2017

0 references

1 reference

4

1 reference

26 December 2017

Ashley I. Bush

10

1 reference

26 December 2017

Colin L. Masters

8

object named as

Colin L Masters

1 reference

26 December 2017

3

Victor L Villemagne

1 reference

26 December 2017

Carlos Opazo

1

object named as

Carlos Opazo

1 reference

26 December 2017

Kevin J Barnham

6

object named as

Kevin J Barnham

1 reference

26 December 2017

author name string

Sandra Luza

2

1 reference

26 December 2017

Christopher Rowe

5

1 reference

26 December 2017

Dorothea Strozyk

7

1 reference

26 December 2017

Robert A Cherny

9

1 reference

26 December 2017

publication date

1 February 2006

1 reference

26 December 2017

published in

Aging Cell

1 reference

26 December 2017

volume

5

1 reference

26 December 2017

page(s)

69-79

1 reference

26 December 2017

issue

1

1 reference

26 December 2017

Dramatic aggregation of Alzheimer abeta by Cu(II) is induced by conditions representing physiological acidosis.

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1474-9726.2006.00196.X

Characterization of Copper Interactions with Alzheimer Amyloid β Peptides

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1474-9726.2006.00196.X

Dietary Cu stabilizes brain superoxide dismutase 1 activity and reduces amyloid Abeta production in APP23 transgenic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1474-9726.2006.00196.X

The metallobiology of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1474-9726.2006.00196.X

Aqueous dissolution of Alzheimer's disease Abeta amyloid deposits by biometal depletion.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1474-9726.2006.00196.X

Treatment with a copper-zinc chelator markedly and rapidly inhibits beta-amyloid accumulation in Alzheimer's disease transgenic mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1474-9726.2006.00196.X

Clioquinol, a drug for Alzheimer's disease specifically interfering with brain metal metabolism: structural characterization of its zinc(II) and copper(II) complexes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1474-9726.2006.00196.X

Metal binding and oxidation of amyloid-beta within isolated senile plaque cores: Raman microscopic evidence

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1474-9726.2006.00196.X

Fast Calculation of Molecular Polar Surface Area as a Sum of Fragment-Based Contributions and Its Application to the Prediction of Drug Transport Properties

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1474-9726.2006.00196.X

The neurobiology of zinc in health and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1474-9726.2006.00196.X

Neuronal zinc exchange with the blood vessel wall promotes cerebral amyloid angiopathy in an animal model of Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1474-9726.2006.00196.X

Alzheimer's disease: Initial report of the purification and characterization of a novel cerebrovascular amyloid protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1474-9726.2006.00196.X

Endoplasmic reticulum and trans-Golgi network generate distinct populations of Alzheimer beta-amyloid peptides

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1474-9726.2006.00196.X

Electrophoretic studies of clioquinol binding to human serum proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1474-9726.2006.00196.X

Correlative Memory Deficits, Abeta Elevation, and Amyloid Plaques in Transgenic Mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1474-9726.2006.00196.X

Zinc-induced Alzheimer's Abeta1-40 aggregation is mediated by conformational factors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1474-9726.2006.00196.X

Cu(II) potentiation of alzheimer abeta neurotoxicity. Correlation with cell-free hydrogen peroxide production and metal reduction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1474-9726.2006.00196.X

Clioquinol treatment in familiar early onset of Alzheimer's disease: a case report

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1474-9726.2006.00196.X

Mutant presenilins specifically elevate the levels of the 42 residue beta-amyloid peptide in vivo: evidence for augmentation of a 42-specific gamma secretase

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1474-9726.2006.00196.X

Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound-B

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1474-9726.2006.00196.X

Contribution by synaptic zinc to the gender-disparate plaque formation in human Swedish mutant APP transgenic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1474-9726.2006.00196.X

The lipophilic metal chelator DP-109 reduces amyloid pathology in brains of human beta-amyloid precursor protein transgenic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1474-9726.2006.00196.X

Copper, iron and zinc in Alzheimer's disease senile plaques.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1474-9726.2006.00196.X

Overexpression of Alzheimer's disease amyloid-beta opposes the age-dependent elevations of brain copper and iron.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1474-9726.2006.00196.X

Soluble pool of Abeta amyloid as a determinant of severity of neurodegeneration in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1474-9726.2006.00196.X

The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1474-9726.2006.00196.X

Styrylbenzoxazole derivatives for in vivo imaging of amyloid plaques in the brain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1474-9726.2006.00196.X

Metalloenzyme-like activity of Alzheimer's disease beta-amyloid. Cu-dependent catalytic conversion of dopamine, cholesterol, and biological reducing agents to neurotoxic H(2)O(2).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1474-9726.2006.00196.X

In vivo reduction of amyloid-beta by a mutant copper transporter

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1474-9726.2006.00196.X

Metal-protein attenuation with iodochlorhydroxyquin (clioquinol) targeting Abeta amyloid deposition and toxicity in Alzheimer disease: a pilot phase 2 clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1474-9726.2006.00196.X

Histochemically-reactive zinc in amyloid plaques, angiopathy, and degenerating neurons of Alzheimer's diseased brains

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1474-9726.2006.00196.X

New insights on how metals disrupt amyloid beta-aggregation and their effects on amyloid-beta cytotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1474-9726.2006.00196.X

Radioiodinated styrylbenzenes and thioflavins as probes for amyloid aggregates.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1474-9726.2006.00196.X

10.1111/J.1474-9726.2006.00196.X

21 January 2018

Identifiers

DOI

1 reference

26 December 2017

PubMed ID

16441845

1 reference

26 December 2017